Publications by authors named "Mark Costen"

Claim this Profile
T
Tissue Plasminogen Activator or Perfluoropropane for Submacular Hemorrhage in Age-Related Macular Degeneration: A Factorial Randomized Clinical Trial.
George S P Murphy, Azahir Saleh, Salma Ayis, Muhammad Raza Cheema, Alex Mehta, Mark Costen

JAMA Ophthalmol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Vangipuram et al.: Timing of delayed retinal pathology in patients presenting with acute posterior vitreous detachment in the IRIS registry (Intelligent Research in Sight). (Ophthalmol Retina. 2023:7:713-720).
Beatrice Gallo, Assad Jalil, Roxane Jo Hillier, Mark Costen, Maria T Sandinha

Ophthalmol Retina· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trial.
Timothy L Jackson, Cristina Soare, Caroline Petrarca, Andrew Simpson, James E Neffendorf, Mark Costen

Br J Ophthalmol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Month-24 Efficacy and Safety of Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration: The MERLOT Randomized Clinical Trial.
Timothy L Jackson, Cristina Soare, Caroline Petrarca, Andrew Simpson, James E Neffendorf, Mark Costen

JAMA Ophthalmol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central retinal artery occlusion during vitrectomy: Immediate retinal revascularization following induction of posterior vitreous detachment.
Abdallah A Ellabban, Ajay D Patil, Mark T Costen, Atiq R Babar

Am J Ophthalmol Case Rep· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epimacular Brachytherapy for Previously Treated Neovascular Age-Related Macular Degeneration (MERLOT): A Phase 3 Randomized Controlled Trial.
Timothy L Jackson, Riti Desai, Andrew Simpson, James E Neffendorf, Robert Petrarca, Mark Costen

Ophthalmology· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scleral hydraulic conductivity and macromolecular diffusion in patients with uveal effusion syndrome.
Timothy L Jackson, Ali Hussain, Ana M S Morley, Paul M Sullivan, Andrea Hodgetts, Mark J Costen

Invest Ophthalmol Vis Sci· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis